Sep 17, 2026 09:02AM
Sep 17, 2026 09:00AM
Aug 20, 2026 09:15AM
Aug 20, 2026 09:15AM
Aug 6, 2026 09:15AM
Aug 6, 2026 09:15AM
Jul 1, 2026 09:01AM Creative Medical Technology issues mid-year pipeline update
Jul 1, 2026 09:00AM
Jun 22, 2026 09:15AM
Jun 22, 2026 09:15AM
Apr 28, 2026 09:02AM
Apr 28, 2026 09:01AM
Jan 13, 2026 09:15AM
Jan 13, 2026 09:15AM Creative Medical Technology Holdings Reaches Major Clinical Inflection Point with Positive Interim Data from ADAPT Trial and CELZ-201 (Olastrocel) in the Treatment of Chronic Lower Back Pain
Dec 17, 2025 09:15AM
Dec 17, 2025 09:15AM
Dec 2, 2025 09:15AM
Dec 2, 2025 09:15AM
Oct 27, 2025 08:15AM
Oct 27, 2025 08:15AM
Aug 13, 2025 09:01AM Creative Medical Technology receives FDA fast track designation for back pain therapy
Aug 13, 2025 09:01AM
Mar 20, 2025 07:50AM
Mar 20, 2025 07:50AM
Feb 20, 2025 08:00AM
Feb 14, 2025 07:00AM
Feb 11, 2025 09:25AM
Feb 11, 2025 09:25AM Creative Medical Technology Reports Positive One-Year Results for AlloStem™ Type 2 Diabetes Program
Nov 13, 2024 09:01AM
Nov 13, 2024 09:00AM
Jul 24, 2024 09:03AM
Jul 24, 2024 09:00AM
Jul 10, 2024 08:32AM
Jul 10, 2024 08:30AM
Jun 24, 2024 08:30AM Creative Medical Technology Holdings Announces Evolutionary Development of its iPSCelz® Program with the Successful Generation of iPSC Derived Islet Cells that Produce Human Insulin
Mar 27, 2024 09:00AM
Mar 7, 2024 09:15AM
Mar 7, 2024 09:15AM
Mar 6, 2024 07:00AM
Mar 6, 2024 07:00AM
Dec 20, 2023 09:38AM
Dec 20, 2023 09:33AM Creative Medical Technology Holdings (NASDAQ:CELZ) Granted FDA Clearance To Begin Phase 1/2 Clinical Trial Of AlloStem(TM) For Addressing Chronic Lower Back Pain
Nov 15, 2023 08:00AM
Oct 10, 2023 08:00AM
Sep 19, 2023 08:01AM
Sep 19, 2023 08:00AM
Aug 24, 2023 10:45AM
Jul 13, 2023 09:00AM
Jun 12, 2023 08:00AM Creative Medical Technology Holdings (CELZ) Provides Corporate Update
Jun 12, 2023 08:00AM

334,272 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All